SEC Form 4/A · accession 0001144204-18-034065
KIORA PHARMACEUTICALS INC · KPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Barbara Wirostko
Officer — Chief Medical Officer
Period of report
Jun 7, 2018
Accepted (ET)
Jun 13, 2018 · 4:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001372514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 7, 2018 | A | 2,215 | $0.52 | A | 52,915 | I | By husband |
| Common StockF1 | Jun 7, 2018 | A | 9,600 | $0.52 | A | 249,997 | D | |
| Common StockF1 | Jun 8, 2018 | A | 7,000 | $0.54 | A | 59,915 | I | By husband |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Form 4 previously filed on June 11, 2018 inadvertently misclassified the 2,215 shares purchased on June 7, 2018 and 7,000 shares purchased on June 8, 2018 as being beneficially owned directly by the reporting person instead of indirectly, and inadvertently omitted the purchase of 9,600 shares by the reporting person on June 7, 2018, which are beneficially owned directly. This amendment corrects that error to add the omitted transaction from June 7, 2018 and to reflect the correct number of shares beneficially owned by the reporting person, both directly and indirectly, after the reported transaction.